These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2536539)

  • 1. Altered central alpha 2-adrenoceptor sensitivity in panic disorder.
    Nutt DJ
    Arch Gen Psychiatry; 1989 Feb; 46(2):165-9. PubMed ID: 2536539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Arch Gen Psychiatry; 1991 Feb; 48(2):157-62. PubMed ID: 1989571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased central alpha 2-adrenoceptor sensitivity in panic disorder.
    Nutt DJ
    Psychopharmacology (Berl); 1986; 90(2):268-9. PubMed ID: 3024199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder.
    Uhde TW; Stein MB; Vittone BJ; Siever LJ; Boulenger JP; Klein E; Mellman TA
    Arch Gen Psychiatry; 1989 Feb; 46(2):170-7. PubMed ID: 2643934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR; Breier A
    Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder.
    Yeragani VK; Tancer M; Uhde T
    Psychiatry Res; 2003 Dec; 121(2):185-96. PubMed ID: 14656453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic and serotonergic receptor system function in panic disorder and depression.
    Heninger GR; Charney DS; Price LH
    Acta Psychiatr Scand Suppl; 1988; 341():138-50. PubMed ID: 3048049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects.
    Cameron OG; Smith CB; Lee MA; Hollingsworth PJ; Hill EM; Curtis GC
    Biol Psychiatry; 1990 Jul; 28(1):3-20. PubMed ID: 2165422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.
    Estan L; Senard JM; Tran MA; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Oct; 101(2):329-36. PubMed ID: 2175232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects.
    Best NR; Rees MP; Barlow DH; Cowen PJ
    Psychoneuroendocrinology; 1992; 17(1):87-93. PubMed ID: 1319072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
    Siever LJ; Uhde TW; Jimerson DC; Lake CR; Silberman ER; Post RM; Murphy DL
    Am J Psychiatry; 1984 Jun; 141(6):733-41. PubMed ID: 6329004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors.
    Grunhaus LJ; Cameron O; Pande AC; Haskett RF; Hollingsworth PJ; Smith CB
    Acta Psychiatr Scand; 1990 Mar; 81(3):216-9. PubMed ID: 2160772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic function in patients with panic anxiety.
    Nesse RM; Cameron OG; Curtis GC; McCann DS; Huber-Smith MJ
    Arch Gen Psychiatry; 1984 Aug; 41(8):771-6. PubMed ID: 6331337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of clonidine on plasma MHPG: evidence against tonic alpha 2-adrenoceptor control of noradrenergic function.
    Nutt DJ; Molyneux SG
    Psychopharmacology (Berl); 1986; 90(4):509-12. PubMed ID: 3027736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine.
    Timmermans PB; Schoop AM; Kwa HY; Van Zwieten PA
    Eur J Pharmacol; 1981 Mar; 70(1):7-15. PubMed ID: 6111465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety.
    Cameron OG; Smith CB; Hollingsworth PJ; Nesse RM; Curtis GC
    Arch Gen Psychiatry; 1984 Dec; 41(12):1144-8. PubMed ID: 6095785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.